LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 254 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 10.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $110,963,511 | -17.0% | 1,851,861 | -0.1% | 0.00% | 0.0% |
| Q2 2023 | $133,626,752 | -2.3% | 1,853,353 | -0.3% | 0.00% | 0.0% |
| Q1 2023 | $136,719,646 | +11.0% | 1,858,614 | +0.8% | 0.00% | 0.0% |
| Q4 2022 | $123,120,082 | -20.3% | 1,843,115 | +2.8% | 0.00% | -40.0% |
| Q3 2022 | $154,432,000 | -2.4% | 1,793,414 | +1.1% | 0.01% | +25.0% |
| Q2 2022 | $158,274,000 | -18.6% | 1,773,974 | +2.7% | 0.00% | -20.0% |
| Q1 2022 | $194,342,000 | -26.7% | 1,727,638 | +0.6% | 0.01% | -16.7% |
| Q4 2021 | $265,166,000 | +10.5% | 1,716,735 | -0.3% | 0.01% | 0.0% |
| Q3 2021 | $239,949,000 | +20.0% | 1,722,291 | +13.0% | 0.01% | +20.0% |
| Q2 2021 | $199,954,000 | -13.6% | 1,524,155 | +0.4% | 0.01% | -16.7% |
| Q1 2021 | $231,455,000 | +59.5% | 1,518,242 | +4.1% | 0.01% | +50.0% |
| Q4 2020 | $145,090,000 | +6.5% | 1,458,925 | +2.1% | 0.00% | -20.0% |
| Q3 2020 | $136,239,000 | -18.1% | 1,429,293 | -3.9% | 0.01% | -16.7% |
| Q2 2020 | $166,277,000 | +43.5% | 1,486,603 | -6.7% | 0.01% | +20.0% |
| Q1 2020 | $115,912,000 | -29.2% | 1,593,950 | +1.5% | 0.01% | -16.7% |
| Q4 2019 | $163,736,000 | +0.2% | 1,570,013 | -4.4% | 0.01% | 0.0% |
| Q3 2019 | $163,450,000 | -16.3% | 1,642,062 | -4.0% | 0.01% | -14.3% |
| Q2 2019 | $195,313,000 | -19.6% | 1,711,021 | -11.4% | 0.01% | -30.0% |
| Q1 2019 | $242,896,000 | -7.2% | 1,932,196 | +0.1% | 0.01% | -16.7% |
| Q4 2018 | $261,881,000 | -54.4% | 1,929,850 | -7.7% | 0.01% | -45.5% |
| Q3 2018 | $573,721,000 | +36.9% | 2,090,137 | +3.3% | 0.02% | +22.2% |
| Q2 2018 | $419,177,000 | +30.7% | 2,023,348 | +4.2% | 0.02% | +28.6% |
| Q1 2018 | $320,699,000 | +26.7% | 1,941,742 | +5.1% | 0.01% | +27.3% |
| Q4 2017 | $253,021,000 | +4.8% | 1,847,814 | +4.2% | 0.01% | 0.0% |
| Q3 2017 | $241,337,000 | +14.1% | 1,772,578 | +1.8% | 0.01% | +10.0% |
| Q2 2017 | $211,457,000 | +18.4% | 1,741,818 | +3.2% | 0.01% | +11.1% |
| Q1 2017 | $178,618,000 | +9.0% | 1,687,618 | +4.6% | 0.01% | 0.0% |
| Q4 2016 | $163,940,000 | +3.0% | 1,613,425 | +3.5% | 0.01% | 0.0% |
| Q3 2016 | $159,147,000 | -12.0% | 1,559,340 | +2.9% | 0.01% | -18.2% |
| Q2 2016 | $180,790,000 | +20.2% | 1,515,814 | +8.0% | 0.01% | +10.0% |
| Q1 2016 | $150,355,000 | +2.8% | 1,404,007 | +4.1% | 0.01% | 0.0% |
| Q4 2015 | $146,199,000 | +28.1% | 1,348,453 | +1.2% | 0.01% | +150.0% |
| Q3 2015 | $114,173,000 | -13.7% | 1,333,017 | +1.6% | 0.00% | -55.6% |
| Q2 2015 | $132,357,000 | +68.8% | 1,311,763 | +29.0% | 0.01% | +80.0% |
| Q1 2015 | $78,411,000 | +47.8% | 1,016,871 | +2.0% | 0.01% | +25.0% |
| Q4 2014 | $53,064,000 | +22.7% | 997,254 | +8.4% | 0.00% | +33.3% |
| Q3 2014 | $43,230,000 | -33.5% | 920,000 | -11.9% | 0.00% | -40.0% |
| Q2 2014 | $65,017,000 | -1.8% | 1,043,782 | +6.0% | 0.01% | -16.7% |
| Q1 2014 | $66,200,000 | +85.1% | 984,239 | +44.7% | 0.01% | +100.0% |
| Q4 2013 | $35,769,000 | +49.6% | 680,017 | +23.1% | 0.00% | +50.0% |
| Q3 2013 | $23,917,000 | +17.7% | 552,609 | +1.8% | 0.00% | 0.0% |
| Q2 2013 | $20,322,000 | – | 543,085 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $8,459 | 3.32% |
| VILLERE ST DENIS J & CO LLC | 480,807 | $35,368,162 | 2.57% |
| Chicago Capital, LLC | 449,508 | $33,065,822 | 1.64% |
| RICE HALL JAMES & ASSOCIATES, LLC | 288,345 | $21,210,681 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 65,163 | $4,793,390 | 0.58% |
| Stephens Investment Management Group LLC | 455,089 | $33,476,347 | 0.56% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 201,993 | $14,858,605 | 0.53% |
| WOODSTOCK CORP | 52,604 | $3,869,550 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,142,607 | 0.41% |
| Jackson Creek Investment Advisors LLC | 12,726 | $936 | 0.39% |